Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 4
2005 3
2006 2
2007 1
2008 1
2009 6
2010 1
2011 2
2012 2
2014 1
2015 2
2016 1
2017 4
2018 6
2019 1
2020 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
The Pre-Interictal Network State in Idiopathic Generalized Epilepsies.
Pitetzis D, Frantzidis C, Psoma E, Ketseridou SN, Deretzi G, Kalogera-Fountzila A, Bamidis PD, Spilioti M. Pitetzis D, et al. Among authors: kalogera fountzila a. Brain Sci. 2023 Dec 2;13(12):1671. doi: 10.3390/brainsci13121671. Brain Sci. 2023. PMID: 38137119 Free PMC article.
Impact of Bevacizumab Versus Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non-small Cell Lung Cancer: A Study by the Hellenic Cooperative Oncology Group.
Mountzios G, Mavropoulou X, Koliou GA, Linardou H, Samantas E, Kosmidis P, Fountzilas G, Charitandi A, Kalogera-Fountzila A. Mountzios G, et al. Among authors: kalogera fountzila a. Anticancer Res. 2020 Apr;40(4):2095-2106. doi: 10.21873/anticanres.14168. Anticancer Res. 2020. PMID: 32234902 Clinical Trial.
Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk.
Boziki MK, Karapanayotides T, Papadopoulos G, Lagoudaki R, Melo P, Bakirtzis C, Nikolaidis I, Gounari E, Tsavdaridou V, Skoura L, Afrantou T, Tatsi T, Grigoriadou E, Polyzoidou E, Mandoras N, Giantzi V, Kalogera-Fountzila A, Ioannidis P, Parissis D, Pelidou SH, Zoidou S, Grigoriadis N. Boziki MK, et al. Among authors: kalogera fountzila a. Neurol Res. 2020 Mar;42(3):209-221. doi: 10.1080/01616412.2020.1722913. Epub 2020 Feb 12. Neurol Res. 2020. PMID: 32048570
Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma.
Psoma E, Koliou GA, Dimitrakopoulos FI, Papadopoulou K, Rontogianni D, Bobos M, Visvikis A, Kosmidis PA, Fountzilas G, Constantinidis J, Kalogera-Fountzila A. Psoma E, et al. Among authors: kalogera fountzila a. Anticancer Res. 2020 Feb;40(2):677-688. doi: 10.21873/anticanres.13997. Anticancer Res. 2020. PMID: 32014908
Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment.
Linardou H, Kotoula V, Kouvatseas G, Mountzios G, Karavasilis V, Samantas E, Kalogera-Fountzila A, Televantou D, Papadopoulou K, Mavropoulou X, Daskalaki E, Zaramboukas T, Efstratiou I, Lampaki S, Rallis G, Res E, Syrigos KN, Kosmidis PA, Pectasides D, Fountzilas G. Linardou H, et al. Among authors: kalogera fountzila a. Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):531-541. doi: 10.21873/cgp.20155. Cancer Genomics Proteomics. 2019. PMID: 31659106 Free PMC article. Clinical Trial.
Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.
Karavasilis V, Samantas E, Koliou GA, Kalogera-Fountzila A, Pentheroudakis G, Varthalitis I, Linardou H, Rallis G, Skondra M, Papadopoulos G, Papatsibas G, Sgouros J, Goudopoulou A, Kalogeras KT, Dervenis C, Pectasides D, Fountzilas G. Karavasilis V, et al. Among authors: kalogera fountzila a. Target Oncol. 2018 Dec;13(6):715-724. doi: 10.1007/s11523-018-0605-y. Target Oncol. 2018. PMID: 30488350 Clinical Trial.
AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.
Pentheroudakis G, Kotoula V, Koliou GA, Karavasilis V, Samantas E, Aravantinos G, Kalogeropoulou L, Souglakos I, Kentepozidis N, Koumakis G, Sgouros J, Zarkavelis G, Efstratiou I, Laschos K, Petraki C, Tikas I, Poulios C, Voutsina A, Goudopoulou A, Bafaloukos D, Vrettou E, Kalogera-Fountzila A, Pectasides D, Fountzilas G. Pentheroudakis G, et al. Among authors: kalogera fountzila a. Clin Colorectal Cancer. 2018 Dec;17(4):e631-e637. doi: 10.1016/j.clcc.2018.06.003. Epub 2018 Jun 15. Clin Colorectal Cancer. 2018. PMID: 29980490 Clinical Trial.
A case report of thrombosed varicosities of pubic collateral veins: Ideal treatment strategy and contribution of era imaging technologies in diagnosis.
Paramythiotis D, Goulas P, Bangeas P, Giannopoulos A, Kapoulas K, Rafailidis V, Papadopoulos G, Ktenidis K, Kalogera-Fountzila A, Michalopoulos A. Paramythiotis D, et al. Among authors: kalogera fountzila a. SAGE Open Med Case Rep. 2018 Feb 12;6:2050313X18757389. doi: 10.1177/2050313X18757389. eCollection 2018. SAGE Open Med Case Rep. 2018. PMID: 29468068 Free PMC article.
39 results